Precision immune regulation for chronic conditions
Low Dose Immunotherapy (LDI) is an innovative treatment designed to retrain and rebalance the immune system using ultra-diluted doses of specific allergens, pathogens, antigens, or autologous samples. These tiny doses are administered sublingually to reduce hypersensitivity, regulate autoimmune responses, and promote long-term immune tolerance. LDI aims to calm inflammation, ease chronic symptoms, and improve overall immune resilience—without suppressing the immune system.
Features
- Ultra-Diluted Antigen Doses
- Sublingual Delivery
- Targets Autoimmune & Inflammatory Conditions
- Personalized Treatment Protocols
- Supports Immune Tolerance
Benefits
- Reduced Chronic Inflammation
- Calms Autoimmune Overactivity
- Relief from Allergies & Sensitivities
- Enhanced Immune Balance
- Safe for Sensitive Patients
Process
Consultation
Thorough evaluation of immune history, triggers, and symptoms.
Antigen Selection
Choose specific antigens or allergens based on testing or patient history.
Dose Administration
Administer LDI via sublingual drops at carefully selected intervals.
Monitoring & Adjustments
Track progress, adjust doses as needed, and refine the treatment plan for lasting results.
Scientific Backing
LDI builds on the foundation of Low Dose Allergen (LDA) therapy and is supported by clinical experience across chronic conditions such as Lyme disease, autoimmune and inflammatory disorders, environmental sensitivities, and chronic fatigue. It leverages principles of immunological tolerance—re-educating the immune system to respond appropriately rather than reactively. Research and anecdotal evidence show promise in symptom relief and immune modulation, especially in patients who are sensitive or unresponsive to conventional care.